• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过杀菌动力学研究确定,与环丙沙星、万古霉素和氨苄西林相比,去甲万古霉素(LY146032)对肠球菌的杀菌活性。

Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.

作者信息

Stratton C W, Liu C, Ratner H B, Weeks L S

机构信息

Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

出版信息

Antimicrob Agents Chemother. 1987 Jul;31(7):1014-6. doi: 10.1128/AAC.31.7.1014.

DOI:10.1128/AAC.31.7.1014
PMID:2821883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC174863/
Abstract

This study used kill-kinetic methods to provide data on the bactericidal activity of subinhibitory (1/2 X MIC), inhibitory (1 x MIC), and suprainhibitory (4X, 6X, and 8X MIC) concentrations of deptomycin (LY146032) against strains of enterococci compared with those of ciprofloxacin, vancomycin, and ampicillin. Deptomycin was the most active agent tested, as determined by broth microdilution methods, with all strains being inhibited at concentrations less than or equal to 2 micrograms/ml. The kill-kinetic demonstrated that deptomycin had greater activity at all concentrations tested than the other cell wall-active agents; regrowth was seen, however, at lower concentrations. At higher concentrations (6X and 8X MIC), all agents tested demonstrated the same or less bactericidal activity than at 4X MIC, presumably due to the Eagle effect. Nevertheless, these results suggest that further evaluation of deptomycin as a therapeutic agent for serious enterococcal infections is warranted.

摘要

本研究采用杀菌动力学方法,提供了去甲万古霉素(LY146032)的亚抑菌浓度(1/2×最低抑菌浓度)、抑菌浓度(1×最低抑菌浓度)以及超抑菌浓度(4×、6×和8×最低抑菌浓度)对肠球菌菌株的杀菌活性数据,并与环丙沙星、万古霉素和氨苄西林进行了比较。通过肉汤微量稀释法测定,去甲万古霉素是所测试的最具活性的药物,所有菌株在浓度小于或等于2微克/毫升时均受到抑制。杀菌动力学表明,去甲万古霉素在所有测试浓度下的活性均高于其他细胞壁活性药物;然而,在较低浓度下可见细菌再生长。在较高浓度(6×和8×最低抑菌浓度)时,所有测试药物的杀菌活性与4×最低抑菌浓度时相同或更低,这可能是由于伊格尔效应。尽管如此,这些结果表明去甲万古霉素作为严重肠球菌感染治疗药物值得进一步评估。

相似文献

1
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.通过杀菌动力学研究确定,与环丙沙星、万古霉素和氨苄西林相比,去甲万古霉素(LY146032)对肠球菌的杀菌活性。
Antimicrob Agents Chemother. 1987 Jul;31(7):1014-6. doi: 10.1128/AAC.31.7.1014.
2
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.通过杀菌动力学研究确定LY146032与甲氧西林、头孢唑林、头孢孟多、头孢呋辛、环丙沙星和万古霉素对葡萄球菌的活性比较。
Antimicrob Agents Chemother. 1987 Aug;31(8):1210-5. doi: 10.1128/AAC.31.8.1210.
3
[Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
Pathol Biol (Paris). 1989 Apr;37(4):263-8.
4
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.达托霉素(LY 146032)与四种对照抗生素单独及联合使用时,对庆大霉素敏感和高水平庆大霉素耐药肠球菌的体外抑制和杀菌活性比较。
Chemotherapy. 1993 Sep-Oct;39(5):302-9. doi: 10.1159/000239141.
5
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.细胞壁活性抗生素杀菌活性的体外反应并不支持肠球菌对这些抗生素天然耐药的普遍观点。
Antimicrob Agents Chemother. 1990 Aug;34(8):1518-22. doi: 10.1128/AAC.34.8.1518.
6
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.肽类抗生素对耐多药屎肠球菌的杀菌活性。
Antimicrob Agents Chemother. 1994 Feb;38(2):385-7. doi: 10.1128/AAC.38.2.385.
7
In vitro activity of LY146032 against gram-positive bacteria.LY146032对革兰氏阳性菌的体外活性。
Diagn Microbiol Infect Dis. 1988 Feb;9(2):79-85. doi: 10.1016/0732-8893(88)90100-9.
8
Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.通过时间杀菌动力学研究确定人血清对达托霉素和万古霉素针对葡萄球菌和肠球菌分离株的杀菌活性的影响。
Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):245-52. doi: 10.1016/0732-8893(90)90067-6.
9
Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.新型缩肽类抗生素LY146032与万古霉素及其他八种药物对革兰氏阳性菌的体外活性比较
J Antimicrob Chemother. 1987 Aug;20(2):191-6. doi: 10.1093/jac/20.2.191.
10
LY146032, alone and in combination with gentamicin, for the treatment of enterococcal pyelonephritis in the rat model.LY146032单独及与庆大霉素联合用于大鼠模型中肠球菌性肾盂肾炎的治疗。
Antimicrob Agents Chemother. 1988 Jan;32(1):81-3. doi: 10.1128/AAC.32.1.81.

引用本文的文献

1
Is It Possible to Optimize the Elaboration and Preservation of a Vancomycin Catheter Lock Solution?是否有可能优化万古霉素导管封管溶液的配制和保存?
Antibiotics (Basel). 2025 Jun 14;14(6):605. doi: 10.3390/antibiotics14060605.
2
Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution-T345I in MprF of clinically isolated MRSA strains.单核苷酸多态性导致达托霉素耐药,导致临床分离的耐甲氧西林金黄色葡萄球菌菌株 mprf 中的氨基酸取代-T345I。
PLoS One. 2021 Jan 22;16(1):e0245732. doi: 10.1371/journal.pone.0245732. eCollection 2021.
3
Paradoxical Antibiotic Effect of Ampicillin: Use of a Population Pharmacokinetic Model to Evaluate a Clinical Correlate of the Eagle Effect in Infants With Bacteremia.氨苄西林的矛盾性抗菌效应:利用群体药代动力学模型评估菌血症婴儿中鹰效的临床相关因素
Pediatr Infect Dis J. 2020 Aug;39(8):725-729. doi: 10.1097/INF.0000000000002663.
4
Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.抗菌药物在儿童和青少年脑脊液中的药代动力学。
Paediatr Drugs. 2013 Apr;15(2):93-117. doi: 10.1007/s40272-013-0017-5.
5
Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.美国早期粪肠球菌临床分离株的克隆性及抗生素耐药性分析。
J Infect Dis. 2009 Nov 15;200(10):1566-73. doi: 10.1086/644790.
6
Assessment of the paradoxical effect of caspofungin in therapy of candidiasis.卡泊芬净治疗念珠菌病时矛盾效应的评估。
Antimicrob Agents Chemother. 2006 Apr;50(4):1293-7. doi: 10.1128/AAC.50.4.1293-1297.2006.
7
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.替考拉宁,一种多功能脂糖肽,可破坏耐甲氧西林金黄色葡萄球菌的细胞壁合成和细胞膜完整性。
Antimicrob Agents Chemother. 2005 Mar;49(3):1127-34. doi: 10.1128/AAC.49.3.1127-1134.2005.
8
Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.卡泊芬净抑制米根霉1,3-β-D-葡聚糖合酶,通过定量PCR检测可降低脑部真菌负荷,并且在小鼠播散性接合菌病中,低剂量而非高剂量时可提高生存率。
Antimicrob Agents Chemother. 2005 Feb;49(2):721-7. doi: 10.1128/AAC.49.2.721-727.2005.
9
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.新型恶唑烷酮类抗菌剂U-100592和U-100766的体外活性
Antimicrob Agents Chemother. 1996 Apr;40(4):839-45. doi: 10.1128/AAC.40.4.839.
10
Frequency and antimicrobial susceptibility of clinical isolates of enterococci.肠球菌临床分离株的频率及抗菌药敏性
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):362-6. doi: 10.1007/BF01964435.

本文引用的文献

1
Combination antibiotic therapy of bacterial endocarditis.细菌性心内膜炎的联合抗生素治疗。
Ann Intern Med. 1980 Mar;92(3):390-5. doi: 10.7326/0003-4819-92-3-390.
2
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.肠球菌杀伤缺陷:作用于细胞壁的抗菌药物的共同特性。
Antimicrob Agents Chemother. 1980 Jun;17(6):965-8. doi: 10.1128/AAC.17.6.965.
3
Enterococcal endocarditis.肠球菌性心内膜炎
Mayo Clin Proc. 1982 Feb;57(2):101-5.
4
Antibiotic-induced lysis of enterococci.抗生素诱导的肠球菌裂解
J Clin Invest. 1981 Sep;68(3):639-45. doi: 10.1172/jci110298.
5
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.对链霉素敏感和链霉素耐药的肠球菌性心内膜炎的治疗。
Ann Intern Med. 1984 Jun;100(6):816-23. doi: 10.7326/0003-4819-100-6-816.
6
Optimal therapy for enterococcal endocarditis.肠球菌性心内膜炎的最佳治疗方法。
Am J Med. 1984 Feb;76(2):186-91. doi: 10.1016/0002-9343(84)90772-1.
7
Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.可转移的β-内酰胺酶。粪肠球菌体外青霉素耐药的一种新机制。
J Clin Invest. 1983 Sep;72(3):1168-71. doi: 10.1172/JCI111042.
8
High-level resistance to gentamicin in clinical isolates of enterococci.肠球菌临床分离株对庆大霉素的高水平耐药性。
J Infect Dis. 1983 Apr;147(4):751-7. doi: 10.1093/infdis/147.4.751.
9
Antibiotic treatment of infective endocarditis.感染性心内膜炎的抗生素治疗
Annu Rev Med. 1983;34:413-27. doi: 10.1146/annurev.me.34.020183.002213.
10
10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality.圣巴塞洛缪医院10年感染性心内膜炎病例分析:临床特征及治疗与预后和死亡率的关系
Lancet. 1980 Jan 19;1(8160):133-6. doi: 10.1016/s0140-6736(80)90614-5.